Fir Tree Capital Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Fir Tree Capital Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-792,269	Closed	-$8.1M	–	314
2023 Q1	$8.1M	Sell	792,269 -161,301	-17%	-$1.64M	0.64%	43
2022 Q4	$9.62M	Sell	953,570 -33	-0%	-$329	0.5%	61
2022 Q3	$9.4M	Buy	953,603 +2,800	+0.3%	+$27.5K	0.32%	95
2022 Q2	$9.26M	Sell	950,803 -49,700	-5%	-$485K	0.29%	105
2022 Q1	$9.77M	Buy	1,000,503 +503	+0.1%	+$4.88K	0.27%	112
2021 Q4	$9.83M	Hold	1,000,000	–	–	0.27%	115
2021 Q3	$9.83M	Buy	+1,000,000	New	+$9.76M	0.33%	89

Fir Tree Capital Management's ORIA Position: Q2 2023 in Review

Fir Tree Capital Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 792,269 shares — an estimated $8.1M sold.

Fir Tree Capital Management first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $9.83M in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Fir Tree Capital Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Fir Tree Capital Management sold 792,269 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $8.1M.
Fir Tree Capital Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
Fir Tree Capital Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $9.83M in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Fir Tree Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.